Department of Biomedical Sciences
Member of the GSBS Faculty
3302 Gaston Ave.
Dallas, Texas 75246
Education and Post-Graduate Training
Postdoctoral Fellowship, Developmental Biology, Protein Chemistry, University of Basel, Switzerland (1993-1999)
Postdoctoral Fellowship, Bioorganic Chemistry, University of California at Santa Barbara (1992-1993)
Ph.D., Biochemistry - Molecular Biology, University of California at Santa Barbara, Interdepartmental Chemistry-Biology (1991)
B.A., Biochemistry - Molecular Biology, University of California at Santa Barbara (1980)
Associate Professor, with tenure, Department of Biomedical Sciences, Texas A&M University Baylor College of Dentistry (2013-present)
Associate Professor, Department of Biomedical Sciences, Texas A&M University Baylor College of Dentistry (2007-2013)
Assistant Professor/Research, Department of Biochemistry, University of Texas Health Science Center at San Antonio (2003-2007)
Visiting Scientist, Structural Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA (2000-2003)
Postdoctoral Scientist, Department of Cell Biology, Biozentrum, University of Basel, Switzerland (1993-1999)
Postdoctoral Scientist, Department of Chemistry, University of California at Santa Barbara (1992-1993)
Lecturer, Upper Division General Biochemistry, Department of Biological Sciences, University of California at Santa Barbara (Jan-Apr, 1987)
Teaching responsibilities include:
- Biochemistry, Cell and Molecular Biology (Dental D1, course 6510, course director 2011- present)
- Biomedical Sciences I and II (Dental Hygiene DH1, courses 3250 and 3340; Biomolecules, Intermediary Metabolism)
- Cell and Molecular Biology of Oral and Craniofacial Tissues (Membranes, Signal Transduction; Biomedical Sciences graduate course 5V40)
Over the last two decades, Dr. Groppe (pronounced GRAWP-ee) has focused on the structure and function of components of the Bone Morphogenetic Protein (BMP) signal transduction pathway, which plays fundamental roles throughout embryonic development, including skeletogenesis of axial, appendicular and craniofacial structures as well as dentition. Initiated as an independent direction in the laboratory of Markus Affolter at the Biozentrum (Basel, Switzerland), the work spawned a collaboration with Senyon Choe, and as a visiting scientist in the Structural Biology Laboratory at the Salk Institute for Biological Studies (La Jolla, California), culminated in determination of crystal structures of BMP-7 trapped by the cystine knot antagonist Noggin (middle right) and complexed with the extracellular domain (one pair/ligand homodimer) of a type II BMP receptor (below right).
As a Research Professor in the Department of Biochemistry at the UT Health Science Center at San Antonio, these studies were extended with Andrew Hinck to investigate the mechanism of cooperative assembly of signaling complexes by structurally related yet functionally distinct ligands, Transforming Growth Factor-βs (TGF-βs). That effort led to the determination of the crystal structure of TGF-β3 (an obligate inducer of palatal fusion) in complex with both pairs (RI/RII) of its receptors (left), revealing quite unexpectedly that the families of structurally related ligands and receptors assemble by strikingly different molecular mechanisms.
Because of their crucial roles in development and disease, rendering them important targets for therapeutic intervention, Noggin and related cystine knot antagonists such as Gremlins 1 and 2 and Cerberus remained the focus of parallel protein structure-function studies supported by an American Heart Association Beginning Grant-in-Aid at the UTHSCSA. After relocating to TAMU Baylor College of Dentistry, SOSTDC1 (Ectodin/USAG1/Wise), a cystine knot antagonist with dual roles in modulating BMP and Wnt signaling during induction and patterning of mammalian dentition, was produced on the milligram scale by refolding of bacterially expressed inclusion body protein and by the baculovirus-insect cell system developed by Max Summers at TAMU.
A second major front in the study of the inhibition of BMP signaling has emerged through collaboration with Frederick Kaplan and Eileen Shore (University of Pennsylvania School of Medicine) who identified a highly conserved gain-of-function mutation in one of four BMP receptor kinases (ALK2) as the source of a severely disabling childhood disorder, Fibrodysplasia Ossificans Progressiva or FOP. Based on a highly reliable structure-based homology model derived from the crystal structure of the TGF-β receptor kinase (ALK5), the common histidine for arginine substitution was hypothesized to further perturb the metastable regulatory region of the BMP receptor kinase, consistent with ligand-independent activation of the receptor in FOP.
Co-crystal structures of ALK2 kinase proteins in complex with small molecule ATP-competitive inhibitors determined by a group at the Structural Genomics Consortium Oxford have confirmed the homology model and allowed for structure-activity relationship (SAR) studies of lead compounds and derivatives. However, despite potency and selectivity, ATP-competitive inhibitors from efforts at Oxford as well as Harvard and Vanderbilt (C. Hong) possess off-target effects that pose a challenge to translation to the clinic and eventual bedside. As a result of our in vitro comparisons of the functions and properties of wildtype, FOP mutant, aspartate-substituted variant (constitutively activated, caALK2) and regulatory subdomain-truncated forms of the receptor kinase with over-expressed recombinant proteins purified to near homogeneity, an alternative, mechanistically novel means of inhibition has been revealed. Through the newly opened avenue, the current focus is on development of a specific therapeutic targeting the dysregulated receptor kinase, which was recently found causative of non-resectable pediatric gliomas, a second severe childhood genetic disease. Thus the need for an ALK2-specific inhibitor has become more important than ever.
- Structural Basis of ACVR1 Dysregulation in Fibrodysplasia Ossificans Progressiva; The Center for Research in Fibrodysplasia Ossificans Progressiva and Related Disorders; University of Pennsylvania School of Medicine; 12/01/06-11/30/13. (PI)
- Mechanisms of BMP Receptor Kinase Dysregulation in Skeletal Dysplasias. NIH/NIAMS R03 (1R03 AR056838-01); 12/15/08-11/30/12. (PI)
- The Roles of FAM20C (DMP4) in Odontogenesis and Osteogenesis. NIH/NIDCR R01 (1R01 DE022549-01A1); 12/01/12 - 11/30/17. (Co-I)
- Novel Allosteric Inhibitors of ALK2 Receptor Kinase. The Center for Research in Fibrodysplasia Ossificans Progressiva and Related Disorders; University of Pennsylvania School of Medicine; 06/01/15-05/31/17 (PI) - [most recent grant from UPenn]
1. Ferguson, J., Groppe, J.C., and Reed, S.I. (1981). Construction and characterization of three yeast-Escherichia coli shuttle vectors designed for rapid subcloning of yeast genes on small DNA fragments. Gene 16:191-197.
2. Reed, S.I., Ferguson, J., and Groppe, J.C. (1982). Preliminary characterization of the transcriptional and translational products of the Saccharomyces cerevisiae cell division cycle gene CDC 28. Mol. Cell. Biol. 2:412-425.
3. Groppe, J.C., and Morse, D.E. (1993). Isolation of full-length RNA templates for reverse transcription from tissues rich in RNase and proteoglycans. Anal. Biochem. 210:337-343.
4. Groppe, J.C., and Morse, D.E. (1993). Molluscan chymotrypsin-like protease: Structure, localization and substrate specificity. Arch. Biochem. Biophys. 305:159-169.
5. Hansma, H.G., Sinsheimer, R.L., Groppe, J., Bruice, T.C., Elings, V., Gurley, Gl., Bezanilla, M., Mastrangelo, I.A., Hough, P.V.C., and Hansma, P.K. (1993). Recent advances in atomic force microscopy of DNA. Scanning15:296-299.
6. He, G.-X., Browne, K.A., Groppe, J.C., Blasko, A., Mei, H-Y., and Bruice, T.C. (1993). Microgonatropens and their interactions with DNA. I. Synthesis of the tri-pyrrole peptides dienmicrogonatropen-a,-b,-c and characterization of their interactions with dsDNA. J. Am. Chem. Soc. 115:7061-7071.
7. Bregnant, T.M., Groppe, J., and Little, R.D. (1994). New class of DNA-cleaving agents based on trimethylenemethane. J. Am. Chem. Soc. 116:3635-3636.
8. Affolter, M., Montagne, J., Walldorf, U., Groppe, J., Kloter, U., LaRosa, M., and Gehring, W.J. (1994). The Drosophila SRF homolog is expressed in a subset of tracheal cells and maps within a genomic region required for tracheal development. Development 120:743-753.
9. Groppe, J.C., and Morse, D.E. (1995). Sequence-independent detection of gene family homologs: Identification of a transcript encoding a molluscan serine protease homologous to the pancreatic enzymes of vertebrates. Comp. Biochem. Physiol. 110B:75-82.
10. Degnan, B.M., Groppe, J.C., and Morse, D.E. (1995). Chymotrypsin mRNA expression in digestive gland amoebocytes: Cell specification occurs prior to metamorphosis and gut morphogenesis in the gastropod, Haliotis rufescens. Roux's Arch. Dev. Biol. 205:97-101.
11. Guillemin, K., Groppe, J., Ducker, K., Treisman, R., Hafen, E., Affolter, M., and Krasnow, M.A. (1996). The pruned gene encodes the Drosophila serum response factor and regulates cytoplasmic outgrowth during terminal branching of the tracheal system. Development 122:1353-1362.
12. Montagne, J., Groppe, J., Guillemin, K., Krasnow, M.A., Gehring, W.J., and Affolter., M. (1996). The Drosophila serum response factor gene is required for the formation of intervein tissue of the wing and is allelic to blistered. Development 122:2589-2597.
13. Groppe, J., Rumpel, K., Economides, A.N., Stahl, N., Sebald, W., and Affolter, M. (1998). Biochemical and biophysical characterization of refolded Drosophila DPP, a homolog of bone morphogenetic proteins 2 and 4. J. Biol. Chem. 273:29052-29065.
14. Nussbaumer, J., Halder, G., Groppe, J., Affolter, M., and Montagne, J. (2000). Expression of the blistered/DSRF gene is controlled by different morphogens during Drosophila trachea and wing development. Mech Dev. 96:27-36.
15. Perrin, M.H., Fischer, W.H., Kunitake, K.S., Craig, A.G., Koerber, S.C., Cervini, L.A., Rivier, J.E., Groppe, J.C., Greenwald, J., Nielsen, S.M., and Vale, W.W. (2001). Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor. J. Biol. Chem.276:31528-31534.
16. Groppe, J., Greenwald., J., Wiater, E., Rodriguez-Leon, J., Economides, A., Kwiatkowski, W., Affolter, M., Vale, W.W., Izpisua-Belmont, J.C., and Choe, S. (2002). Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420:636-642.
[Commented on by Wrana, J. (2002). Structural biology: On the wings of inhibition. Nature 420:613-614; also highlighted by UCSD/Nature Signaling Gateway (Dec 2002). BMP signal inhibition by Noggin: The shape of things to come, online].
17. Greenwald, J., Groppe, J., Gray, P., Wiater, E., Kwiatkowski, W., Vale, W.W., and Choe, S. (2003). The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell. 11:605-617.
[Commented on by Sebald, W., and Mueller, T.D. (2002). The interaction of BMP-7 and ActRll implicates a new mode of receptor assembly. Trends Biochem Sci 28:518-521 and Sun, P.D. (2003). Conserved in structure but diverse in recognition. Structure 11:362-363.]
18. Groppe, J., Greenwald, J. Wiater, E., Rodriguez-Leon, J., Economides, A., Kwiatkowski., W. Baban, K., Affolter, M., Vale, W.W., Izpisúa-Belmonte, J.C., and Choe, S. (2003). Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cystine knot protein. J. Bone Joint Surg. Am 85-A, Supplement 3: 52-58.
19. Ilangovan, J., Ding, W., Zhong, Y., Wilson, C.L., Groppe, J.C., Trbovich, J.T., Zúñiga, J., Demeler, B., Tang, Q., Gao, L., Mulder, K.M., and Hinck, A.P. (2005). Structure and dynamics of the homodimeric dynein light chain km23. J. Mol. Biol. 352:338-354.
20. Zúñiga, J.E., *Groppe, J.C., Cui, Y., Hinck, C.S., Contreras-Shannon, V., Pakhomova, O.N., Yang, J., Tang, Y., Mendoza, V., López-Casillas, F., Sun, L.-Z., and Hinck, A.P. (2005). Assembly of TβRI:TβRII:TGFβ ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent. J. Mol. Bio. 354:1052-1068 (*equal first author, wrote paper).
21. Groppe, J.C., Shore, E.M., and Kaplan, F.S. (2007). Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin. Orthop. Relat. Res. 462:87-92.
22. Kaplan, F.S., Groppe, J., Pignolo, R.J., and Shore, E.M. (2007). Morphogen receptor genes and metamorphogenes: Skeleton keys to metamorphosis. Ann. NY Acad. Sci. 1116:113-133.
23. Groppe, J., Hinck, C.S., Samavarchi-Tehrani, P., Zubieta, C., Schuermann, J.P., Taylor, A.B., Schwarz, P.M., Wrana, J.L., and Hinck, A.P. (2008). Cooperative assembly of TGF-β superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol. Cell 29:157-168.
[Commented on by Massagué, J. (2008). A very private TGF-β receptor embrace. Mol. Cell 29:149-150; Gough, N.R. (2008). Monogamy in the TGF-β receptor relationship. Science Signaling Vol 1 (5):46; and Montoya, M., (2008). Signaling distinctions. Nat. Struct. Mol. Biol. 15:227.]
24. Kaplan, F.S., Le Merrer, M., Glaser, D.L., Pignolo, R.J., Goldsby, R.E., Kitterman, J.A., Groppe, J., and Shore, E.M. (2008). Fibrodysplasia ossificans progressiva. Best Pract. Res. Clin. Rheumatol. 22:191-205.
25. Kaplan, F.S., Shen, Q., Lounev, V., Seeman, P., Groppe J., Katagiri T., Pignolo, R.J., and Shore, E.M. (2008). Skeletal metamorphosis in Fibrodysplasia Ossificans Progressiva (FOP). J. Bone Miner. Res. 26:521-530.
26. Kaplan, F.S., Groppe, J., and Shore, E.M. (2008). When one skeleton is enough: Approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP). Drug Discov. Today Ther. Strateg. 5:255-262.
27. Kaplan, F.S., Xu, M., Seemann, P., Connor, M., Glaser, D.L., Carroll, L., Delai, P., Fastnacht-Urban, E., Forman, S.J., Gillessen-Kaesbach, G., Hoover-Fong, J., Köster, B., Pauli, R.M., Reardon, W., Zaidi, S.-A., Zasloff, M., Morhart, R., Mundlos, S., Groppe, J., and Shore, E.M. (2009). Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum. Mutat. 30:379-90.
28. Wang, Y., Groppe, J.C., Wu, J., Ogawa ,T., Mues, G., D'Souza, R.N., and Kapadia, H. (2009). Pathogenic mechanisms of tooth agenesis linked to paired domain mutations in human PAX9. Hum. Mol. Genet. 18:2863-2874.
29. Nickel, J., Sebald, W., Groppe, J.C., and Mueller, T.D. (2009). Intricacies of BMP receptor assembly. Cytokine Growth Factor Rev. 20:367-77.
30. Seemann, P., Brehm, A., König, J., Reissner, C., Stricker, S., Kuss, P., Haupt ,J., Renninger, S., Nickel, J., Sebald, W., Groppe, J.C., Plöger, F., Pohl, J., Schmidt-von Kegler, M., Walther, M., Gassner, I., Rusu, C., Janecke, A.R., Dathe, K., and Mundlos, S. (2009). Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN. PloS Genet. 5:e1000747.
31. Kaplan, F.S., Groppe, J., Seeman, P., Pignolo, R.J., and Shore, E.M. (2010). Fibrodysplasia ossificans progressiva: Developmental implications of a novel metamorphogene. Bone and Development (Vol. 6). Topics in Bone Biology, Chapter 14. Bronner, Farach-Carson and Roach, editors.
32. Kuhfahl, S., Hauburger, A., Thieme, T., Groppe, J., Ihling, C., Tomic, S., Schutkowski, M., Sinz, A., and Schwarz, E. (2011). Identification of a core domain within the proregion of bone morphogenetic proteins that interacts with the mature, dimeric domain. Biochem. Biophys. Res. Commun. 408:300-305.
33. Groppe, J., Wu, J., Shore, E.M., and Kaplan, F.S. (2011). In vitro analysis of the dysregulated R206H ALK2 Kinase-FKBP12 interaction associated with heterotopic ossification in FOP. Cells Tissues Organs 194:291-295.
34. Zúñiga, J.E., Ilangovan, U., Mahlawat, P., Hinck, C.S., Huang, T., Groppe, J.C., McEwen, D.G., and Hinck, A.P. (2011). The TβR-I pre-helix extension is structurally ordered in the unbound form and its flanking prolines are essential for binding J. Mol. Biol. 412: 601-618.
35. Ishii, Y., Takizawa, T., Iwasaki, H., Fujita, Y., Murakami, M., Groppe, J.C., and Tanaka, K. (2012). Nucleotide polymorphisms in the canine Noggin (NOG) gene and their distribution among dog (Canis lupus familiaris) breeds. Biochemical Genetics 50: 12-18.
36. Zimmer, J., Doelken, S., Horn, D., Groppe, J., Shore, E., Kaplan, F., and Seemann, P. (2012). Functional analysis of alleged NOGGIN mutation G92E disproves its pathogenic relevance. PLoS ONE 7(4): e35062.
37. Wang, X., Wang, S., Li, C., Gao, T., Liu, Y., Rangiani, A., Sun, Y., Hao, J., George, A., Lu, Y., Groppe, J., Yuan, B., Feng, J., and Qin C. (2012). Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice. PLoS Genetics 8(5): e1002708.
38. Whitman, M., Rosen, V., Brivanlou, A.H., Groppe, J.C., Sebald, W., and Mueller, T. (2013). Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3. Nat Med 19:809-810.
39. Kaplan, F.S., Kobori, J.A., Orellana, C., Calvo, I., Rosello, M., Martinez, F., Lopez, B., Xu, M., Pignolo, R.J., Shore, E.M., and Groppe, J.C. (2015). Multi-System Involvement in a Severe Variant of Fobrodysplasia Ossificans Progressiva (ACVR1 c. 772G>A; R258G): A Report of Two Patients. Am J Med Genet A. June 11. doi: 10.1002/ajmg.a.37205. (Epub ahead of print].